天大药业(00455)发布中期业绩 股东应占亏损3323.7万港元 同比扩大22.03%

Group 1 - The company Tian Da Pharmaceutical (00455) reported a revenue of HKD 137 million for the first half of 2025, representing a year-on-year decrease of 12.45% [1] - The company's loss attributable to shareholders widened to HKD 33.237 million, an increase of 22.03% compared to the previous year [1] - The basic loss per share was reported at HKD 1.55 cents [1]